WINTON GROUP Ltd Sells 28,835 Shares of CVS Health (CVS)

WINTON GROUP Ltd cut its holdings in shares of CVS Health (NYSE:CVS) by 30.8% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 64,748 shares of the pharmacy operator’s stock after selling 28,835 shares during the period. WINTON GROUP Ltd’s holdings in CVS Health were worth $4,694,000 at the end of the most recent reporting period.

Several other large investors have also bought and sold shares of the company. Bontempo Ohly Capital Mgmt LLC increased its position in shares of CVS Health by 0.5% during the second quarter. Bontempo Ohly Capital Mgmt LLC now owns 21,830 shares of the pharmacy operator’s stock worth $1,756,000 after acquiring an additional 109 shares in the last quarter. ELCO Management Co. LLC increased its position in shares of CVS Health by 1.4% during the second quarter. ELCO Management Co. LLC now owns 15,900 shares of the pharmacy operator’s stock worth $1,279,000 after acquiring an additional 215 shares in the last quarter. Auxier Asset Management increased its position in shares of CVS Health by 0.6% during the second quarter. Auxier Asset Management now owns 67,449 shares of the pharmacy operator’s stock worth $5,427,000 after acquiring an additional 400 shares in the last quarter. Sii Investments Inc. WI increased its position in shares of CVS Health by 2.2% during the second quarter. Sii Investments Inc. WI now owns 20,381 shares of the pharmacy operator’s stock worth $1,630,000 after acquiring an additional 443 shares in the last quarter. Finally, Psagot Investment House Ltd. increased its position in shares of CVS Health by 0.9% during the second quarter. Psagot Investment House Ltd. now owns 52,421 shares of the pharmacy operator’s stock worth $4,218,000 after acquiring an additional 447 shares in the last quarter. 83.97% of the stock is owned by institutional investors.

How to Become a New Pot Stock Millionaire

CVS opened at $65.12 on Monday. The company has a debt-to-equity ratio of 0.59, a quick ratio of 0.52 and a current ratio of 1.02. The stock has a market capitalization of $66,066.33, a price-to-earnings ratio of 11.04, a P/E/G ratio of 1.11 and a beta of 1.05. CVS Health has a twelve month low of $60.14 and a twelve month high of $84.00.



CVS Health (NYSE:CVS) last released its earnings results on Thursday, February 8th. The pharmacy operator reported $1.92 earnings per share for the quarter, beating the Zacks’ consensus estimate of $1.88 by $0.04. The firm had revenue of $48.39 billion for the quarter, compared to analysts’ expectations of $47.54 billion. CVS Health had a net margin of 3.58% and a return on equity of 17.21%. The company’s quarterly revenue was up 5.3% on a year-over-year basis. During the same period in the previous year, the company earned $1.71 earnings per share. research analysts anticipate that CVS Health will post 6.32 earnings per share for the current fiscal year.

The business also recently announced a quarterly dividend, which will be paid on Thursday, May 3rd. Shareholders of record on Monday, April 23rd will be paid a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a yield of 3.07%. The ex-dividend date is Friday, April 20th. CVS Health’s payout ratio is 33.90%.

Several equities research analysts have recently commented on the stock. Bank of America decreased their target price on shares of CVS Health from $91.00 to $88.00 and set a “buy” rating for the company in a research report on Wednesday, April 11th. Leerink Swann set a $85.00 price target on shares of CVS Health and gave the stock a “buy” rating in a report on Tuesday, April 10th. Citigroup set a $77.00 price target on shares of CVS Health and gave the stock a “neutral” rating in a report on Tuesday, February 13th. Robert W. Baird cut their price target on shares of CVS Health from $85.00 to $80.00 and set a “neutral” rating on the stock in a report on Friday, February 9th. Finally, Royal Bank of Canada set a $89.00 price target on shares of CVS Health and gave the stock a “buy” rating in a report on Thursday, February 8th. Two equities research analysts have rated the stock with a sell rating, seven have issued a hold rating, twelve have issued a buy rating and two have assigned a strong buy rating to the stock. CVS Health presently has a consensus rating of “Buy” and a consensus target price of $86.65.

In other CVS Health news, EVP Helena Foulkes sold 19,965 shares of the business’s stock in a transaction dated Friday, February 16th. The shares were sold at an average price of $71.04, for a total value of $1,418,313.60. Following the transaction, the executive vice president now directly owns 65,072 shares in the company, valued at $4,622,714.88. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. 0.61% of the stock is owned by insiders.

COPYRIGHT VIOLATION NOTICE: This news story was published by StockNewsTimes and is the property of of StockNewsTimes. If you are viewing this news story on another website, it was illegally copied and republished in violation of U.S. & international copyright & trademark laws. The original version of this news story can be read at https://stocknewstimes.com/2018/04/23/winton-group-ltd-sells-28835-shares-of-cvs-health-cvs.html.

CVS Health Profile

CVS Health Corporation, together with its subsidiaries, provides integrated pharmacy health care services. It operates through Pharmacy Services and Retail/LTC segments. The Pharmacy Services segment offers pharmacy benefit management solutions, such as plan design and administration, formulary management, Medicare Part D services, mail order, specialty pharmacy and infusion services, retail pharmacy network management services, prescription management systems, clinical services, disease management programs, and medical pharmacy management services.

Institutional Ownership by Quarter for CVS Health (NYSE:CVS)

Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply